These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 6252867

  • 1. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
    Alenius S.
    Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
    [Abstract] [Full Text] [Related]

  • 2. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC, Grill S, Derse D, Chen JY, Caradonna SJ, Connor K.
    Biochim Biophys Acta; 1981 Jan 29; 652(1):90-8. PubMed ID: 6260189
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
    Smith KO, Galloway KS, Ogilvie KK, Cheriyan UO.
    Antimicrob Agents Chemother; 1982 Dec 29; 22(6):1026-30. PubMed ID: 6297382
    [Abstract] [Full Text] [Related]

  • 6. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A, Ericson AC, Sohl-Akerlund A, Datema R.
    J Gen Virol; 1988 Jun 29; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
    Harmenberg JG, Svensson LT.
    Acta Virol; 1988 Mar 29; 32(2):153-5. PubMed ID: 2899962
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ, Gray JJ.
    Br J Ophthalmol; 1990 May 29; 74(5):286-8. PubMed ID: 2162190
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    Alenius S, Berg M, Broberg F, Eklind K, Lindborg B, Oberg B.
    J Infect Dis; 1982 Apr 29; 145(4):569-73. PubMed ID: 6279738
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B.
    Pharmacol Ther; 1982 Apr 29; 19(3):387-415. PubMed ID: 6201932
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.
    Reno JM, Lee LF, Boezi JA.
    Antimicrob Agents Chemother; 1978 Feb 29; 13(2):188-92. PubMed ID: 206200
    [Abstract] [Full Text] [Related]

  • 19. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM, Lee KW, Hinze HC.
    Arch Virol; 1980 Feb 29; 66(3):261-4. PubMed ID: 6449917
    [Abstract] [Full Text] [Related]

  • 20. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
    Harmenberg J, Wahren B, Sundqvist VA, Levén B.
    J Antimicrob Chemother; 1985 May 29; 15(5):567-73. PubMed ID: 2989239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.